You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 103 No. 1, January 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  CORRESPONDENCE
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Bisulfite Intolerance Manifest as Bronchospasm Following Topical Dipivefrin Hydrochloride Therapy for Glaucoma

Howard J. Schwartz, MD; Theodore H. Sher, MD
Cleveland

Arch Ophthalmol. 1985;103(1):14-15.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Sulfites are widely used in the food and pharmacology industry as sanitizing and preservative agents. Sulfiting agents include potassium metabisulfite, potassium bisulfite, sodium bisulfite, sodium sulfite, and sulfur dioxide. These chemicals are also used in the fast-food and restaurant industry in a wide variety of foods, including salads, fresh fruits, potatoes, wine, and shellfish.1 Sensitivity to sulfiting agents has been recognized as a cause of wheezing in a substantial number of asthmatic patients, when exposed both via the oral2-6 or inhaled routes,7-10 but anaphylaxis, generalized urticaria, flushing, and acute gastrointestinal tract symptoms can also be the initial manifestion of sulfite sensitivity.

A sterile ophthalmic topical solution, containing dipivefrin 0.1% and sodium metabisulfite as an antioxidant preservative, presents the unsuspecting asthmatic patient with an additional source of exposure to an agent capable of triggering an idiopathic flare of respiratory tract difficulty. To our knowledge, . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.